Relationship of human liver dihydrodiol dehydrogenases to hepatic bile-acid-binding protein and an oxidoreductase of human colon cells

  • Kazuya MATSUURA
    Biochemistry Laboratory, Gifu Pharmaceutical University, Mitahora-higashi, Gifu 502, Japan
  • Yoshiyuki TAMADA
    Biochemistry Laboratory, Gifu Pharmaceutical University, Mitahora-higashi, Gifu 502, Japan
  • Kumiko SATO
    Biochemistry Laboratory, Gifu Pharmaceutical University, Mitahora-higashi, Gifu 502, Japan
  • Yoshiyuki MIYABE
    Biochemistry Laboratory, Gifu Pharmaceutical University, Mitahora-higashi, Gifu 502, Japan
  • Yoshihiro DEYASHIKI
    Biochemistry Laboratory, Gifu Pharmaceutical University, Mitahora-higashi, Gifu 502, Japan
  • Naoko ISHIDA
    Biochemistry Laboratory, Gifu Pharmaceutical University, Mitahora-higashi, Gifu 502, Japan

書誌事項

公開日
1996-01-15
DOI
  • 10.1042/bj3130373
公開者
Portland Press Ltd.

この論文をさがす

説明

<jats:p>We previously isolated three monomeric dihydrodiol dehydrogenases, DD1, DD2 and DD4, from human liver, and cloned a cDNA (C9) thought to encode DD2, which is identical with those for human bile-acid-binding protein and an oxidoreductase of human colon carcinoma HT29 cells. In the present study we have provided evidence that the C9 cDNA clone encodes DD1, not DD2. A recombinant enzyme expressed from the cDNA in a bacterial system was purified, and its catalytic properties, bile-acid-binding ability and primary sequence were compared with those of the hepatic dihydrodiol dehydrogenases. The results show that DD1 encoded by C9 possesses prostaglandin F synthase activity but low affinity for lithocholic acid, whereas DD2, showing differences of six amino acid residues from the DD1 sequence, exhibited high-affinity binding for the bile acid. Refined relationship between dihydrodiol dehydrogenases and their related proteins of human tissues is proposed.</jats:p>

収録刊行物

被引用文献 (5)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ